Tuesday, November 24, 2009, 9:21pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Omrix Biopharmaceuticals, Inc. (OMRI)

On Nov 17: 18.13 USD   0.00 (0.00%)  
MORE ON OMRI
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Omrix Biopharmaceuticals, Inc. (NGM:OMRI) Delayed quote dataEdit
Last Trade: 18.13 USD
Trade Time: Nov 17
Change: 0.00 (0.00%)
Prev Close: 18.13
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 45.30
Day's Range: N/A - N/A
52wk Range: 8.99 - 36.30
Volume: 0
Avg Vol (3m): 618,153
Market Cap: N/A
P/E (ttm): 20.30
EPS (ttm): 0.89
Div & Yield: N/A (N/A%)
Omrix Biopharmaceuticals, Inc. (OMRI)
1d  5d  3m  6m  1y  2y  5y 
 Add OMRI to Portfolio   Download Data

HEADLINES
King Beats, but Earnings Down
Zacks.com (Thu, Nov 5)
[video] They Just Don't Get Merck-Schering!
at TheStreet.com (Tue, Mar 10)
[video] They Just Don't Get Merck-Schering!
at TheStreet.com (Mon, Mar 9)
[video] Against the Grain: Sell Pfizer!
at TheStreet.com (Wed, Mar 4)
[video] Against the Grain: Sell Pfizer!
at TheStreet.com (Wed, Mar 4)
[video] They Just Don't Get Pfizer!
at TheStreet.com (Mon, Jan 26)
The NYT, JNJ & That Tricky "Billion"
at CNBC (Mon, Jan 5)
Big Predictions For Big Pharma
at Investopedia (Fri, Jan 2)
Cramer's M&A Plays
at CNBC (Wed, Dec 3)
Discounts in Biotech Keep Pharma M&A Rolling
at TheStreet.com (Wed, Dec 3)
Law Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, Inc. -- OMRI
Marketwire (Wed, Dec 3)
More Headlines for OMRI...

ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops and markets biosurgical and immunotherapy products derived from human plasma. The company offers a fibrin sealant, used as an adjunct to hemostasis in liver surgery as Evicel in...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices